Whether this unexpected phenotype results from the inhibition of other TTP-dependent inflammatory processes (e.g., cytokine expression) altering the tumor microenvironment and fostering tumor progression remains currently unknown and needs further investigation [96,115]. This evidence concerns the gene ZFP36 and neoplasm.